* Allergan and Richter announce positive phase iii results
for ulipristal acetate 5 and 10 mg in treatment of uterine
fibroids
The post BRIEF-Allergan and Richter say new drug application for treatment of uterine fibroids planned to be submitted in 2017 appeared first on NASDAQ.